Markets & Regulations

(Image: Getty/BrianAJackson)

AZ’s ADC receives priority review

By Ben Hargreaves

US FDA provides AZ and Daiichi Sankyo’s ADC for the treatment of metastatic breast cancer priority review, with a decision set for Q2 2020.

(Image: Getty/Natali Mis)

Hired and Retired: Jumping on gene therapy

By Ben Hargreaves

The gene therapy space is a rapidly developing areas in the industry, as a result those with expertise are finding their knowledge is invaluable to companies looking to advance in the space.

Follow us


View more